The New CHEST Guidelines on Antithrombotic Therapy for Atrial Fibrillation Should Consider Recent Data on Rivaroxaban

Autor: Kim, Y-H, Shim, J, Tsai, C-T, Wang, C-C, Vilela, G, Muengtaweepongsa, S, Kurniawan, M, Maskon, O, Hsu, LF, Nguyen, TH, Sim, K, Camm, AJ
Jazyk: angličtina
Rok vydání: 2019
ISSN: 1931-3543
Databáze: OpenAIRE